Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 14/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9080563 | 1.00 | HTR1A (1.00) | HTR1AHTR2AHTR2CHTR2BDRD2 | |
| Hydrochloric Acid SCHEMBL8900399 | 0.99 | HTR1A (0.97) | HTR1AHTR2AHTR2CHTR2BDRD2 | |
| Hydrochloric Acid SCHEMBL8900402 | 0.99 | HTR1A (0.97) | HTR1AHTR2AHTR2CHTR2BDRD2 | |
| SCHEMBL8808092 | 0.84 | HTR1A (0.73) | HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8808085 | 0.84 | HTR1A (0.73) | HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL8810279 | 0.82 | HTR1A (1.00) | HTR1ADRD2 | |
| SCHEMBL8810282 | 0.82 | HTR1A (1.00) | HTR1ADRD2 | |
| SCHEMBL3375158 | 0.82 | HTR1A (1.00) | HTR1A | |
| SCHEMBL8525515 | 0.82 | HTR1A (1.00) | HTR1A | |
| Hydrochloric Acid SCHEMBL8899835 | 0.81 | HTR1A (0.98) | HTR1ADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5486611-A | CENTRAL NERVOUS SYSTEM | THE UPJOHN COMPANY (US) | 1996-01-23 | — | — | US | disclosed |
| EP-0548664-B1 | 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives | HOFFMANN LA ROCHE (CH) | 1995-05-31 | — | — | EP | disclosed |
| US-5318967-A | Cognition activators for alzheimer's disease, learning enhancement | HOFFMANN-LA ROCHE INC. (US) | 1994-06-07 | — | — | US | disclosed |
| US-5318966-A | Administering the enzyme inhibitor for treating alzheimer's disease, learning enhancement, brain disorders | HOFFMANN-LA ROCHE INC. (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0548664-A1 | 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1993-06-30 | — | — | EP | disclosed |